Refreshed Look Spotlights Most Diverse Breast
Implant Portfolio for a Customized Look
IRVINE,
Calif., Nov. 8, 2023 /PRNewswire/ -- Allergan
Aesthetics, an AbbVie company (NYSE: ABBV), embraces the
immensely personal choice that patients experience when choosing
breast surgery. The new Natrelle® campaign, "For
Every BODY," highlights patients and their diverse stories,
leveraging new imagery and visual assets which can be seen at
www.alookforeverybody.com. The campaign showcases how the
Natrelle® breast implant portfolio can provide a
customized look for every curve, for every shape, and for every
BODY.
"Our market research shows how important it is to consumers for
breast implant brands to showcase a wide range of real, authentic
women in marketing efforts,1*" said Carrie Strom, President, Global Allergan
Aesthetics and Senior Vice President, AbbVie. "The decision to get
breast surgery is a personal choice, and we are excited to share
our evolved visual identity that further celebrates the uniqueness
of every woman."
During market research, consumers who have undergone breast
augmentation surgery and those considering a breast augmentation
also cite the importance of seeing candid images of women engaging
in various activities.1* Additionally, consumers stated
they needed to see women with breast implants modeling various
fashions, helping to demonstrate what day-to-day life with breast
implants can look like.1* This new campaign, once fully
launched, will help anyone interested in learning more about breast
implants better understand what real outcomes may look like.
With Natrelle®, patients can get a customized
look they love. Natrelle® is the number one
selected breast implant by plastic surgeons,2† with
a collection of 300 implant options to choose from.3
Natrelle® offers the most options for smooth
breast implants with five profiles, from minimal to maximum
fullness, and three different gummy gels for different levels of
softness.3‡ Gummy describes the
consistency of the silicone gel in Natrelle
INSPIRA® Breast Implants. Each type of implant in the
Natrelle INSPIRA® Collection has a different
level of cohesivity.3‡
"Every day in my practice, I see a wide range of women who are
considering breast surgery for a variety of reasons," said
Camille G. Cash, MD, Board-Certified
Plastic Surgeon. "I am glad that Natrelle®
is taking this first step to help show the world how incredible
these women are. As their surgeon, I develop a close relationship
with them, and hope that the Natrelle® 'For Every
BODY' campaign will help more women better understand the options
available to them, making it easier for them to make an informed
decision as part of the consultation."
To learn more and see the refreshed branding, visit
natrelle.com or @Natrelle on YouTube, and follow along at
Instagram @NatrelleBreastAugmentation,
@NatrelleBreastReconstruction, and #ForEveryBODY.
*Based on March 2023 consumer
market research (n=38).
†Based on July 2023
surgeon data (n=305).
‡ Significance inside the body has not been
established.
Natrelle® Breast Implants
IMPORTANT SAFETY INFORMATION AND APPROVED USES
Breast implants are not considered lifetime devices. The
longer people have them, the greater the chances are that they will
develop complications, some of which will require more
surgery.
Breast implants have been associated with the development of
a cancer of the immune system called breast
implant–associated anaplastic large cell lymphoma (BIA-ALCL).
This cancer occurs more commonly in patients with textured breast
implants than smooth implants, although rates are not well defined.
Some patients have died from BIA-ALCL.
Patients receiving breast implants have reported a variety of
systemic symptoms, such as joint pain, muscle aches, confusion,
chronic fatigue, autoimmune diseases, and others. Individual
patient risk for developing these symptoms has not been well
established. Some patients report complete resolution of symptoms
when the implants are removed without replacement.
Who can get breast
implants?
Natrelle® Breast Implants are
approved for the following:
- Breast augmentation for women at least 22 years old
for silicone-filled implants and for women at least 18 years old
for saline-filled implants. Breast augmentation includes
primary breast augmentation to increase the breast size and
revision surgery to correct or improve the result of a primary
breast augmentation
- Breast reconstruction. This includes primary breast
reconstruction to replace breast tissue that has been removed due
to cancer or trauma or that has failed to develop properly due to a
severe breast abnormality. This also includes revision surgery to
correct or improve the result of a primary breast
reconstruction
Who should NOT get breast implants?
Breast implant
surgery should NOT be performed in:
- Women with active infection anywhere in their body
- Women with existing cancer or precancer of their breast who
have not received adequate treatment for those conditions
- Women who are currently pregnant or nursing
What should I tell my doctor?
Tell your doctor if you
have any of the following conditions, as the risks of breast
implant surgery may be higher:
- Autoimmune diseases (eg, lupus and scleroderma)
- A weakened immune system (eg, taking medications to decrease
the body's immune response)
- Planned chemotherapy or radiation therapy following breast
implant placement
- Conditions or medications that interfere with wound healing and
blood clotting
- Reduced blood supply to breast tissue
- Clinical diagnosis of depression or other mental health
disorders, including body dysmorphic disorder and eating
disorders
- Those with a diagnosis of depression or other mental health
disorders should wait for resolution or stabilization of these
conditions prior to undergoing breast implantation surgery
What else should I consider?
- There is a Boxed Warning for breast implants. Please see bold
text at beginning
- Many changes to your breasts following implantation are
irreversible. If you later choose to have your implants removed and
not replaced, you may experience dimpling, puckering, wrinkling, or
other cosmetic changes, which may be permanent
- Breast implantation is likely not a one-time surgery. The
longer implants are in place, the greater the potential risk for
complications. You will likely need additional surgeries on your
breasts due to complications or unacceptable cosmetic results.
Thus, you should also consider the complication rates for later
(revision) surgery since you may experience these risks in the
future
- Cancer treatments and surgery will affect the outcome and
timing of breast reconstruction
- Breast implants may affect your ability to breastfeed,
either by reducing or eliminating milk production
- Rupture of a silicone-filled breast implant is most often
silent. Even if you have no symptoms, you should have your first
ultrasound or MRI at 5 to 6 years after your initial implant
surgery and then every 2 to 3 years thereafter regardless of
whether your implants are for augmentation or reconstruction. If
you have symptoms of or uncertain ultrasound results for breast
implant rupture, an MRI is recommended. Additional imaging may be
required depending on your medical history and status. The health
consequences of a ruptured silicone gel-filled breast implant have
not been fully established
- Routine screening mammography for breast cancer will be more
difficult, and implants may rupture during the procedure. Perform
self-examination every month for cancer screening and ask your
surgeon to help you distinguish the implant from your breast
tissue. Lumps, persistent pain, swelling, hardening, or changes in
implant shape should be reported to your surgeon and possibly
evaluated with imaging
What are key complications with breast implants?
Key
complications include reoperation, implant removal with or without
replacement, implant rupture with silicone-filled implants, implant
deflation with saline-filled implants, and capsular contracture
(severe scar tissue around the implant). Other complications
include breast pain, swelling, asymmetry, wrinkling/rippling,
implant malposition nipple complications, hypertrophic scarring,
and implant palpability/visibility.
Talk to your doctor about other complications.
For more information, see the patient brochures at
www.allergan.com/products.
To report a problem with Natrelle® Breast
Implants, please call Allergan® at
1-800-624-4261.
The sale and distribution of Natrelle® Breast
Implants is restricted to licensed physicians who provide
information to patients about the risks and benefits of breast
implant surgery.
About Allergan Aesthetics
At Allergan Aesthetics, an AbbVie company, we develop, manufacture,
and market a portfolio of leading aesthetics brands and products.
Our aesthetics portfolio includes facial injectables, body
contouring, plastics, skin care, and more. Our goal is to
consistently provide our customers with innovation, education,
exceptional service, and a commitment to excellence, all with a
personal touch. For more information,
visit AllerganAesthetics.com.
About AbbVie
AbbVie's mission is to discover and deliver innovative medicines
and solutions that solve serious health issues today and address
the medical challenges of tomorrow. We strive to have a remarkable
impact on people's lives across several key therapeutic areas –
immunology, oncology, neuroscience, and eye care – and products and
services in our Allergan Aesthetics portfolio. For more information
about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on
Twitter, Facebook, Instagram, YouTube and LinkedIn.
References
- Allergan. Data on File. Consumer Market Research. 2023.
- Surgeon Data Survey. July
2023.
- Allergan Data on File at Natrelle®.
2023.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/natrelle-unveils-new-for-every-body-campaign-301980875.html
SOURCE AbbVie